Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes
Clinical trial NCT06891157 · RECRUITING
Trial details
- NCT number
- NCT06891157
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-20
- Primary completion
- 2027-08-20
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.